Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before‐and‐after groups

Abstract

The randomized interventional comparative trial in a small ICU patient group suggested the potential cost-benefit of clinical pharmacy on daily ICU drug costs. However, after matching, this benefit was attenuated. A final conclusion demands a larger randomized trial adopting a similar design with matched controls. Future research should include clinical impact of recommendations.